{
    "root": "557418b9-7ce2-4f89-bc1a-f4c76ca98025",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Diclofenac Potassium",
    "value": "20250502",
    "ingredients": [
        {
            "name": "DICLOFENAC POTASSIUM",
            "code": "L4D5UA6CB4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4508"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "MEDIUM-CHAIN TRIGLYCERIDES",
            "code": "C9H2L21V7U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB13959"
        },
        {
            "name": "NONCRYSTALLIZING SORBITOL SOLUTION",
            "code": "9E0S3UM200",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_75958"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "LECITHIN, SOYBEAN",
            "code": "1DI56QDM62",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_61995"
        }
    ],
    "indications": {
        "text": "diclofenac potassium capsules indicated relief mild moderate acute pain adult pediatric patients 12 years age older . ( 1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "lowest effective shortest duration consistent individual patient treatment goals ( 2.1 ) 25 mg four times day",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "diclofenac potassium capsules 25 mg , translucent , pale yellow , liquid-filled capsules printed `` 25 `` black ink supplied : ndc number 72336-432-12 bottles 120 capsules storage store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] . protect moisture light . dispense tight , light resistant container defined usp .",
    "adverseReactions": "diclofenac potassium capsules contraindicated following patients : known hypersensitivity ( e.g . , anaphylactic serious skin ) diclofenac components product [ ( 5.7 , 5.9 ) ] history asthma , urticaria , allergic-type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids reported patients [ ( 5.7 , 5.8 ) ] setting coronary artery bypass graft ( cabg ) surgery [ ( 5.1 ) ] diclofenac potassium capsules contains gelatin contraindicated patients known hypersensitivity bovine protein .",
    "indications_original": "Diclofenac Potassium Capsules are indicated for relief of mild to moderate acute pain in adult and pediatric patients 12 years of age and older. (1)",
    "contraindications_original": "Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals ( 2.1 ) The dosage is 25 mg four times a day",
    "warningsAndPrecautions_original": "Diclofenac Potassium Capsules 25 mg, are translucent, pale yellow, liquid-filled capsules printed with \"25\" in black ink supplied as:\n                  NDC Number\u00a072336-432-12\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Bottles of 120 Capsules\n                  \n                     Storage \n                  \n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted between 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature].\n                  Protect from moisture and light. Dispense in a tight, light resistant container as defined in USP.",
    "adverseReactions_original": "Diclofenac Potassium Capsules are contraindicated in the following patients:\n                  \n                     Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product [see Warnings and Precautions (5.7, 5.9)]\n                     History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients[see Warnings and Precautions (5.7, 5.8)]\n                     In the setting of coronary artery bypass graft (CABG) surgery [see Warnings and Precautions (5.1)]\n                     Diclofenac Potassium Capsules contains gelatin and is contraindicated in patients with known hypersensitivity to bovine protein.",
    "drug": [
        {
            "name": "Diclofenac Potassium",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4508"
        }
    ]
}